Asana Initiates Phase 1 Trial of New Therapy for Colorectal, Other Solid Tumors
Asana BioSciences is enrolling participants for a Phase 1 clinical trial assessing the safety, tolerability, and effectiveness of AS003 in patients with advanced solid tumors with the BRAF V600 mutation or with ... Read more